# Early Feasibility Study of the MyoRegulator® for Treatment of ALS

> **NCT06165172** · NA · COMPLETED · sponsor: **PathMaker Neurosystems Inc.** · enrollment: 5 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DEVICE:** MyoRegulator®

## Key facts

- **NCT ID:** NCT06165172
- **Lead sponsor:** PathMaker Neurosystems Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-21
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-08-31
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2025-03-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06165172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06165172, "Early Feasibility Study of the MyoRegulator® for Treatment of ALS". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06165172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*